1-3 of 3
Haiyang Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The dual-target molecular glue degrader INNO-235 effectively mediates the degradation of GSPT1 and CK1α, and exhibits potent anti-tumor activity in TP53 mutant burkitt lymphoma

Free
Minghao Sun, Shi Feng, Qingbo Hao, Haiyang Wang, Ran Kong, Cong Wang, Michael Haughey, Derek Mendy, Patrick Papa, Weilin Xie, Xiangxiang Zhou
Journal: Blood
Blood (2025) 146 (Supplement 1): 5091.
https://doi.org/10.1182/blood-2025-5091
Published: 2025
Journal Articles

A Highly Selective and Orally Bioavailable CK1α Molecular Glue Degrader Targets B-Cell Lymphoma Cells

Free
Ran Kong, Shi Feng, Cong Wang, Qingbo Hao, Yu Zhang, Jingjing Han, Xiaoyu Xie, Haiyang Wang, Jan Elsner, Derek Mendy, Michael Haughey, Paul Krenitsky, Veronique Plantevin-Krenitsky, Patrick Papa, Frank Mercurio, Weilin Xie, Xiangxiang Zhou
Journal: Blood
Blood (2024) 144 (Supplement 1): 956.
https://doi.org/10.1182/blood-2024-208315
Published: 2024
Journal Articles

Acute myeloid leukemia with GATA2 and WT1 mutations mimicking acute promyelocytic leukemia

Free
Hongwei Chen, Haiyang Wang
Journal: Blood
Blood (2024) 143 (3): 290.
https://doi.org/10.1182/blood.2023022453
Published: 2024